SERPINB2 and ovarian carcinoma: SERPINB2, also named Plasminogen Activator Inhibitor, Type II (PAI-2) is upregulated by numerous inflammatory conditions [58]; in cancer disease its expression is often an indicator of positive prognosis as described in ovarian cancer [59, 60].